In addition, blocking NF-κB and sEH as well as enabling PPARα and PPARγ expression could alleviate neurodegenerative diseases such as Alzheimer’s disease (Certo et al., 2015, Prashantha et al., 2020). The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.